SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-130938
Filing Date
2022-04-29
Accepted
2022-04-29 09:15:32
Documents
8
Period of Report
2022-06-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A d291624ddef14a.htm DEF 14A 589162
2 GRAPHIC g291624g01d13.jpg GRAPHIC 25403
3 GRAPHIC g291624g16n01.jpg GRAPHIC 185258
4 GRAPHIC g291624g39u12.jpg GRAPHIC 30489
5 GRAPHIC g291624g70d01.jpg GRAPHIC 201531
6 GRAPHIC g291624g70d02.jpg GRAPHIC 172489
7 GRAPHIC g291624g80a43.jpg GRAPHIC 50977
8 GRAPHIC g291624g91b29.jpg GRAPHIC 48664
  Complete submission text file 0001193125-22-130938.txt   1559043
Mailing Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39567 | Film No.: 22870738
SIC: 2836 Biological Products, (No Diagnostic Substances)